If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.20
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.30 (25.00%)
Open: 1.35
High: 1.35
Low: 1.35
Prev. Close: 1.35
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

22 Feb 2022 07:00

RNS Number : 3396C
Image Scan Holdings PLC
22 February 2022
 

22 February 2022

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Image Scan Holdings plc

("Image Scan" or the "Company")

 

Trading update ahead of AGM

Image Scan, (AIM: IGE) specialists in the field of real-time X-ray imaging for the security and industrial inspection markets, provides an update ahead of its Annual General Meeting being held later today.

Key points:

· New portable X-ray system launched at Dubai security show

· Image Scan appointed global distributor for Serstech AB

· Portable X-ray sale to US Federal agency

· Change of board roles from 1 January

· Trading continues to be impacted by COVID-19

· Company will be loss-making for the first half of the financial year

· Board considers the loss may not be recovered by end of the financial year

 

 

The new ThreatScan®-AS1 fully integrated portable X-ray system, together with a new, high energy, X-ray generator, was launched at a Dubai security exhibition held in January and there were encouraging levels of interest from both customers and trading partners. Manufacturing of the first batch of production units is about to start, and some of these will be used as demonstrators by our sales team and international sales partners. The first sale of a portable X-ray system to a US Federal agency was an important milestone in our targeting of the North American market.

 

Sales of the Company's industrial scanners continue to be impacted by disruption in the automotive industry, where both customer demand and global supply chains have been adversely affected by COVID-19. However, the Company recently received an order for a new machine and has been performing trial inspections of parts for a potential new customer in the same industry. As part of its diversification plan, trial inspections of parts for a fuel cell company have also been carried out.

 

Initiatives to further expand the footprint of the Company included entering into a distributor agreement with Serstech AB, under which we are taking their sophisticated, hand-held chemical analysers to the global security market.

 

As part of the Board's succession plan, Vincent Deery was appointed as Interim CEO on 1 January 2022. William Mawer now performs the role of Executive Chairman.

 

In the first half of FY22, COVID-19 has continued to impact customer spending, the operation of our sales and service functions, our international supply chain, and our staff. Orders have been delayed, causing the momentum built up in the second half of FY21 to stall. This is now expected to result in the Company making a significant loss for the first half.

 

The result for the year as a whole was, and still is, expected to be second half weighted but while we have a strong pipeline of orders across many parts of the world, the timing of those orders is hard to predict in the current environment, and the Board therefore believes it is unlikely that the second half will be sufficiently strong to enable the Company to fully recover the first half loss.

 

Bill Mawer, Chairman and Chief Executive Officer of Image Scan commented: "It is disappointing that our order intake has stalled in the first half of the year. While international travel for trade shows and demonstrations is still limited, we have a healthy pipeline of new business. However, it will take some time for that business to come through. Together with the loss of COVID-19 Government support mechanisms, this gives us less confidence in our original expectation for the current financial year. The positive response to the launch of our new products gives us confidence for the longer term but, in the continuing, challenging environment, it has to be expected that it will take a while for order levels to recover."

The Company's Annual General Meeting, which will take place on 22 February at 13.30. It will be a hybrid meeting, with options for attendance at its Barrow-upon-Soar facility and on-line. The Board will make a brief video presentation available on the Company's website www.3dx-ray.com immediately after the AGM.

The Company will provide further detail in its interim results in April 2022.

-ENDS-

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

Enquiries:

Image Scan Holdings plc

William Mawer, Executive Chairman

Sarah Atwell King, Finance Director and Company Secretary

Tel: +44 (0) 1509 817 400

ir@ish.co.uk

W H Ireland - Nominated Adviser and Broker

Mike Coe/Sarah Mather

Tel: +44 (0) 207 220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDDGXDDGDB
Date   Source Headline
31st Mar 20059:15 amRNSImage Scan Announces Placing
21st Mar 20058:45 amRNSDirector Declaration
8th Mar 200511:22 amRNSRe Contract
16th Feb 20058:45 amRNSProduct Launch
31st Jan 20054:39 pmRNSDirectorate Change
27th Jan 20055:12 pmRNSFinal Results
7th Jan 200510:39 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.